Cargando…
Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease
Autoimmune liver diseases (AILD) include autoimmune hepatitis (AIH), primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). These immune-mediated liver diseases involve a break down in peripheral self-tolerance with largely unknown aetiology. Regulatory T cells (Treg) are crucia...
Autores principales: | Richardson, N., Wootton, G. E., Bozward, A. G., Oo, Y. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256571/ https://www.ncbi.nlm.nih.gov/pubmed/35641679 http://dx.doi.org/10.1007/s00281-022-00940-w |
Ejemplares similares
-
Autoimmune Hepatitis: Tolerogenic Immunological State During Pregnancy and Immune Escape in Post-partum
por: Bozward, Amber G., et al.
Publicado: (2020) -
Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy
por: Bozward, Amber G., et al.
Publicado: (2021) -
Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade
por: Bozward, Amber G., et al.
Publicado: (2021) -
Type 2 Autoimmune Hepatitis and Nonadherence to Medication Correlate With Premature Birth and Risk of Postpartum Flare
por: Olsen, Kathryn, et al.
Publicado: (2021) -
Regulatory T-Cell Therapy in Liver Transplantation and Chronic Liver Disease
por: Hann, Angus, et al.
Publicado: (2021)